New SEC Form D filing
Animal Biosciences, Inc., 2026-09-09
A new SEC Form D private-offering notice from Boston, MA, a $2,610,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Develops longevity therapies and supplements for companion animals such as dogs, cats, and horses.
New filing todayFiled to raise $2,610,000First money in 2026-08-17Raised so far $2,320,000HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified animalbioscience.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- General Cybernetics Corp, 2026-09-09, $15.3M, Boston, MA
- Cloverleaf Bio, Inc., 2026-09-09, $29.6M, New Haven, CT
- Sonagram Inc., 2026-09-08, $1M, Stoughton, MA
- Iambic Therapeutics, Inc., 2026-09-09, $66.5M, San Diego, CA
- Sute Media Inc., 2026-09-04, $1M, Watertown, MA
- Airway Therapeutics, Inc., 2026-09-09, $50.6M, Marietta, GA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.